PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date27/01/22 → 26/01/27

Keywords

  • phase 2 trial
  • treatment safety
  • treatment efficacy
  • ovarian cancer